Molecular pathology of the X-linked hyper-immunoglobulin M syndrome: Detection of wild-type transcripts in a patient with a complex splicing defect of the CD40 ligand

Clinical and Diagnostic Laboratory Immunology

Volumn 3, Issue 6, 1996, Pages 722-726

  Ameratunga, Roman ^a,b,e   McKee, Jeff ^a   French, John ^a,c   Prestidge, Ross ^a,f   Fanslow, William ^d   Marbrook, John ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c GREEN LANE HOSPITAL   (New Zealand)

^d AMGEN INC   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

^f Genesis Research & Development Corporation Ltd   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M;

ADULT; ARTICLE; CASE REPORT; DNA SEQUENCE; HUMAN; HYPERIMMUNOGLOBULINEMIA M; IMMUNE DEFICIENCY; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA SPLICING; RNA TRANSCRIPTION; X CHROMOSOME LINKAGE;

EID: 0029860098     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.3.6.722-726.1996     Document Type: Article

References (23)

1. Allen, R. C., R. J. Armitage, M. E. Conley, et al. 1993. CD40 ligand gene defects responsible for X-linked hyper IgM syndrome. Science 259:990-993.
2. Armitage, R. J., W. C. Fanslow, L. Strockbine et al. 1992. Molecular and biological characterisation of a murine ligand for CD40. Nature (London) 357:80-82.
3. Aruffo, A., M. Farrington, U. Hollenbaugh, et al. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291-300.
4. Ausubel, F. M., R. Brent, R. E. Kingston, et al. 1991. Current protocols in molecular biology. Wiley Interscience, New York.
5. Boyhan, A., C. M. Casimir, J. K. French, C. G. Teahan, and A. W. Segal. 1992. Molecular cloning and characterisation of grancalcin, a novel EF-Hand calcium binding protein abundant in neutrophils and monocytes. J. Biol. Chem. 267:2928-2933.
6. Callard, R. E., S. Smith, J. Herbert, el al. 1994. CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM): a comparison of X-linked, autosomal recessive and non-X linked forms of the disease, and obligate carriers. J. Immunol. 153:3295-3306.
7. Clarke, E. A., and J. A. Ledbetter. 1986. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc. Natl. Acad. Sci. USA 83:4494-4498.
8. DiSanto, J. P., J. Y. Bonnefoy, J. F. Gauchat, A. Fischer, and G. de Saint Basile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature (London) 361:541-543.
9. Fanslow, W. C., D. M. Anderson, K. H. Grabstein, E. A. Clark, D. Cosman, and R. J. Armitage. 1992. Soluble forms of CD40 inhibit biologic responses of human B cells. J. Immunol. 149:655-660.
10. Fanslow, W. C., S. Srinivasan, R. Paxton, M. G. Gibson, M. K. Spriggs, and R. J. Armitage. 1996. Structural characteristics of CD40 ligand that determine biological function. Semin. Immunol. 6:267-278.
11. Fuleihan, R., N. Ramesh, R. Loh, et al. 1993. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA 90:2170-2173.
12. Hollenbaugh, D., L. H. Wu, H. D. Ochs, et al. 1994. The random inactivation of the X chromosome carrying the defective gene responsible for X-linked hyper IgM syndrome (X-HIGM) in female carriers of HIGM1. J. Clin. Invest. 94:616-622.
13. Jabara, H. H., S. M. Fu, R. S. Geha, and I). Vercelli. 1990. CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 172:1861-1864.
14. Konig, G., C. L. Masters, and K. Beyreuther. 1990. Retinoic acid induced differentiated neuroblastoma cells show increased expression of the beta A4 amyloid gene of Alzheimer's disease and an altered splicing pattern. FEBS Lett. 269:305-310.
15. Korthauer, U., D. Graf, H. W. Mages, et al. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature (London) 361:539-541.
16. Krawczak, M., J. Reiss, and D. N. Cooper. 1992. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum. Genet. 90:41-54.
17. Notarangelo, L., M. Duse, and A. Ugazio. 1992. Immunodeficiency with hyper IgM (HIM). Immunodefic. Rev. 3:101-121.
18. Ramesh, N., R. Fuleihan, V. Ramesh, et al. 1993. Deletions in the ligand for CD40 in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1). Int. Immunol. 5:769-773.
19. Ramesh, N., R. Fuleihan, P. Swinton, F. S. Rosen, and R. Geha. 1995. A point mutation in exon 2 of the CD40 ligand gene causes the simultaneous expression of two defective mRNA species in X-linked hyperimmunoglobulinemia M. Hum. Mol. Genet. 4:759-761.
20. Rieger, C. H. L., J. W. Moohr, and R. M. Rothberg. 1974. Correction of neutropenia associated with dysgammaglobulinemia. Pediatrics 54:508-511.
21. Rosen, F. S., S. V. Kevy, E. Merler, C. A. Janeway, and D. Gitlin. 1961. Recurrent bacterial infections and dysgammaglobulinemia: deficiency of 7S gammaglobulins in the presence of elevated 19S gammaglobulins. Pediatrics 28:182-195.
22. Shapiro, M. B., and P. Senapathy. 1987. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res. 15:7155-7173.
23. Villa, A., L. D. Notarangelo, J. P. DiSanto, et al. 1994. Organisation of the human CD40 ligand gene: implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis. Proc. Natl. Acad. Sci. USA 91:2110-2114.